ESMO Real World Data and Digital Oncology Health Informatics
339P AI-CROSS: Can artificial intelligence predict response to neoadjuvant chemoradiotherapy (CROSS) in gastro-oesophageal junction adenocarcinoma? A prospective randomized trial
The publisher did not provide an abstract — full text is available via the link below.